Trends in adverse drug reactions between 2011 and 2022 in a tertiary hospital in China through retrospective analysis

Author:

Liu Yao1,Yang Liu1,Li Teng1,Yang Lisha1,Li Yaling1,wu zhigui1

Affiliation:

1. Affiliated Hospital of Southwest Medical University

Abstract

Abstract Adverse drug reactions (ADRs) are unavoidable phenomena in the process of medication administration and can easily cause harm to patients. In order to understand the characteristics and patterns of ADRs, this article analyses the ADR reported by a tertiary hospital in China from 2011 and 2022. We retrospectively analyzed the trends of ADRs over these 10 years, including the distribution of ADRs, basic patient profiles, evaluation of the association of ADRs, route of administration, classification of drugs, and organs/systems involved in the ADRs. From 2011 to 2022, a total of 7,367 ADRs were reported. Over this 10-year period, the proportion of infants has been decreasing, and the rate of the juvenile group and the senior citizen has been increasing. The highest number of ADRs occurred via intravenous infusion. Among the organs/systems involved in adverse drug reactions, the skin and its accessories were mostly damaged, but the rate of ADRs in blood system increased significantly. Antibacterial drugs were the first cause of adverse drug reactions, followed by anti-tumor drugs. Through the changes related to ADRs in the past 10 years, we need to pay more attention to the adverse drug reactions caused by drugs, and further strengthen the monitoring of ADRs to reduce the occurrence of ADRs, and decrease the damage caused by adverse drug reactions, to ensure the life and health of patients.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3